<DOC>
	<DOC>NCT01506635</DOC>
	<brief_summary>In this randomized controlled clinical trial, we compare the effects of timolol versus placebo for treatment of myopic regression after LASIK</brief_summary>
	<brief_title>Effect of Timolol on Refractive Outcomes in Eyes With Myopic Regression After LASIK: a Randomized Clinical Trial</brief_title>
	<detailed_description />
	<mesh_term>Myopia</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<criteria>Patients with myopic regression equal or more than 0.5 D with minimum age of 20 years, cylinder â‰¤ 1.00 D, corrected distance visual acuity (CDVA) of at least 20/40 were included. Patients with a history of previous ocular surgery, keratoconus or any ectatic corneal disorder, keratoconus suspect by topography, preoperative corneal opacity, any corneal dystrophies, presence of pterygium, retinal disorders, collagen vascular disorders, diabetes mellitus, glaucoma, cataract, pregnancy, breast feeding systemic corticosteroid therapy were excluded.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>